Academia and industry collaboration in dermatology research
Keywords:Academia, Industry, Collaboration, Dermatology Research
AbstractThe assessment of cause of illness and new innovations to treat the illness is exciting at all point of time. Research is the key to any new innovations. The hindrance in development of new innovations can be multifaceted in terms of resources which may not only be limited to talent acquisition and financial resources. Collaborations among different stake holders in research such as industry, government and academia are important and should be encouraged by government to promote research, development and innovation. Currently biomedical researchers in the United States and from the international community are focusing increasingly on relationships between industry and academia and their effects on the conduct and results of research studies. Formerly rigidly separated research efforts in academic and industry have become increasingly transparent to each other. This transparency between industry and academia has created opportunities for more rapid translation of basic discoveries to patient needs. Collaborations among industry and academia can hasten the development of new technologies to clinical practice leading to significant health advancements. Collaboration between industry and academia facilitates quality research projects with identified impact objectives within a shorter time span.
Als-Nielsen, B, Chen, W, Gluud, C, Kjaergard, LL. Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events? JAMA 2003;290:921-8.
Baird P. Getting it right: Industry sponsorship and medical research. CMAJ 2003;168:1267-9.
Danforth W (Task Force Chair): Task Force on Financial Conflicts of Interest in Clinical Research: Protecting Subjects, Preserving Trust, Promoting Progress—Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research. 2001 Washington, DC: American Association of Medical Colleges web reference, http://www.aamc.org/members/coitf/firstreport.pdf.
Bauer EA, Cohen DE. The changing roles of industry and academia. J Invest Dermatol. 2012 Mar;132(3 Pt 2):1033-6.
Prendergast MM, Abramovits W, Boguniewicz M, Lebwohl M, Tokar M, Tong KB. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology. J Invest Dermatol. 2004 Sep;123(3):452-4.